Literature DB >> 16742482

Studies on guanine deaminase and its inhibitors in rat tissue.

S Kumar1, V Josan, K C Sanger, K K Tewari, P S Krishnan.   

Abstract

1. In kidney, but not in rat whole brain and liver, guanine-deaminase activity was localized almost exclusively in the 15000g supernatant fraction of iso-osmotic sucrose homogenates. However, as in brain and liver, the enzymic activity recovered in the supernatant was higher than that in the whole homogenate. The particulate fractions of kidney, especially the heavy mitochondria, brought about powerful inhibition of the supernatant guanine-deaminase activity. 2. In spleen, as in kidney, guanine-deaminase activity was localized in the 15000g supernatant fraction of iso-osmotic sucrose homogenates. However, the particulate fractions did not inhibit the activity of the supernatant. 3. Guanine-deaminase activity in rat brain was absent from the cerebellum and present only in the cerebral hemispheres. The inhibitor of guanine deaminase was located exclusively in the cerebellum, where it was associated with the particles sedimenting at 5000g from sucrose homogenates. 4. Homogenates of cerebral hemispheres, the separated cortex or the remaining portion of the hemispheres had significantly higher guanine-deaminase activity than homogenates of whole brain. The enzymic activity of the subcellular particulate fractions was nearly the same. 5. Guanine deaminase was purified from the 15000g supernatant of sucrose homogenates of whole brain. The enzyme separated as two distinct fractions, A and B, on DEAE-cellulose columns. 6. The guanine-deaminase activity of the light-mitochondrial fraction of whole brain was fully exposed and solubilized by treatment with Triton X-100, and partially purified. 7. Tested in the form of crude preparations, the inhibitor from kidney did not act on the brain and liver supernatant enzymes and the inhibitor from cerebellum did not act on kidney enzyme, but the inhibitor from liver acted on both brain and kidney enzyme. 8. The inhibitor of guanine deaminase was purified from the heavy mitochondria of whole brain and liver and the 5000g residue of cerebellum, isolated from iso-osmotic homogenates. The inhibitor appeared to be protein in nature and was heat-labile. The inhibition of the enzyme was non-competitive. 9. Kinetic, immunochemical and electrophoretic studies with the preparations purified from brain revealed that the enzyme from light mitochondria was distinct from enzyme B from the supernatant. A distinction between the two forms of supernatant enzyme was less certain. 10. Guanine deaminase isolated from light mitochondria of brain did not react with 8-azaguanine or with the inhibitor isolated from heavy mitochondria.

Entities:  

Year:  1967        PMID: 16742482      PMCID: PMC1270316          DOI: 10.1042/bj1020691

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  BRAIN GUANINE DEAMINASE: PURIFICATION, PROPERTIES AND REGIONAL DISTRIBUTION.

Authors:  M MANSOOR; G D KALYANKAR; G P TALWAR
Journal:  Biochim Biophys Acta       Date:  1963-10-01

2.  GUANINE-DEAMINASE ACTIVITY IN RAT BRAIN AND LIVER.

Authors:  S KUMAR; K K TEWARI; P S KRISHNAN
Journal:  Biochem J       Date:  1965-06       Impact factor: 3.857

3.  Guanase activity in normal and neoplastic human tissue.

Authors:  R LEVINE; T C HALL; C A HARRIS
Journal:  Cancer       Date:  1963-02       Impact factor: 6.860

4.  Properties of the two forms of malic dehydrogenase from beef heart.

Authors:  F C GRIMM; D G DOHERTY
Journal:  J Biol Chem       Date:  1961-07       Impact factor: 5.157

5.  Characterisation of two malic dehydrogenases from rat liver.

Authors:  C J THORNE
Journal:  Biochim Biophys Acta       Date:  1960-07-29

6.  An absorption apparatus for the micro-determination of certain volatile substances: The determination of urea and ammonia in body fluids.

Authors:  E J Conway
Journal:  Biochem J       Date:  1933       Impact factor: 3.857

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  Deamination of 8-azaguanine by guanase.

Authors:  A ROUSH; E R NORRIS
Journal:  Arch Biochem       Date:  1950-11

9.  Enzymatic deamination of 8-azaguanine in normal and neoplastic tissues.

Authors:  E HIRSCHBERG; J KREAM; A GELLHORN
Journal:  Cancer Res       Date:  1952-07       Impact factor: 12.701

10.  Multiple forms of mitochondrial malate dehydrogenases.

Authors:  G B Kitto; P M Wassarman; J Michjeda; N O Kaplan
Journal:  Biochem Biophys Res Commun       Date:  1966-01-04       Impact factor: 3.575

View more
  12 in total

1.  A novel transition state analog inhibitor of guanase based on azepinomycin ring structure: Synthesis and biochemical assessment of enzyme inhibition.

Authors:  Saibal Chakraborty; Niti H Shah; James C Fishbein; Ramachandra S Hosmane
Journal:  Bioorg Med Chem Lett       Date:  2010-11-27       Impact factor: 2.823

2.  Induction of guanine deaminase and its inhibitor in rodent liver and brain.

Authors:  A Sitaramayya; S Ali; K S Kumar; P S Krishnan
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

3.  Guanine deaminase in rat liver and mouse liver and brain.

Authors:  K S Kumar; A Sitaramayya; P S Krishnan
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

4.  Purification of guanine deaminase inhibitor from human brain.

Authors:  S Kumar; M Rathi
Journal:  Neurochem Res       Date:  1980-05       Impact factor: 3.996

5.  Identification of small molecule compounds with higher binding affinity to guanine deaminase (cypin) than guanine.

Authors:  José R Fernández; Eric S Sweet; William J Welsh; Bonnie L Firestein
Journal:  Bioorg Med Chem       Date:  2010-07-27       Impact factor: 3.641

6.  Cypin: A novel target for traumatic brain injury.

Authors:  Przemyslaw Swiatkowski; Emily Sewell; Eric S Sweet; Samantha Dickson; Rachel A Swanson; Sara A McEwan; Nicholas Cuccolo; Mark E McDonnell; Mihir V Patel; Nevin Varghese; Barclay Morrison; Allen B Reitz; David F Meaney; Bonnie L Firestein
Journal:  Neurobiol Dis       Date:  2018-07-19       Impact factor: 5.996

7.  Purine ribonucleotide biosynthesis, interconversion and catabolism in mouse brain in vitro.

Authors:  P C Wong; J F Henderson
Journal:  Biochem J       Date:  1972-10       Impact factor: 3.857

8.  Modulation of guanine deaminase.

Authors:  K S Kumar; A Sitaramayya; P S Krishnan
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

9.  Analogs of iso-azepinomycin as potential transition-state analog inhibitors of guanase: synthesis, biochemical screening, and structure-activity correlations of various selectively substituted imidazo[4,5-e][1,4]diazepines.

Authors:  Saritha Tantravedi; Saibal Chakraborty; Niti H Shah; James C Fishbein; Ramachandra S Hosmane
Journal:  Bioorg Med Chem       Date:  2013-07-11       Impact factor: 3.641

10.  Characterization of Xenopus laevis guanine deaminase reveals new insights for its expression and function in the embryonic kidney.

Authors:  Paula G Slater; Garrett M Cammarata; Connor Monahan; Jackson T Bowers; Oliver Yan; Sangmook Lee; Laura Anne Lowery
Journal:  Dev Dyn       Date:  2019-02-19       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.